frailty adaptive therapy in newly diagnosed myeloma patients | maria victoria mateos, md | eha 2024
Published 1 month ago • 75 plays • Length 4:34Download video MP4
Download video MP3
Similar videos
-
5:46
dreamm-7 trial update (belavd vs daravd) in rrmm | maria victoria mateos, md | eha 2024
-
4:08
frailty and multiple myeloma | hira mian, md, msc | ash 2022
-
1:25
are frailty scores being used in clinical trials? how?
-
5:31
frontline and car-t cell therapy for multiple myeloma | xavier leleu, md, msc, phd | eha 2024
-
1:26
how is frailty defined? what does it mean to be fit, intermediate fit, and frail?
-
58:19
sequencing bcma myeloma therapies
-
7:38
asco/eha myeloma updates 2024 | claudio cerchione, md | eha 2024
-
2:31
asco/eha 2024 myeloma highlights- imroz, dreamm-7, dreamm-8 | joshua richter, md | eha 2024
-
3:16
end stage multiple myeloma
-
3:06
the role of artificial intelligence for precision medicine in multiple myeloma
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
1:51
management of multiple myeloma in frail/elderly patients
-
2:25
cevostamab in rrmm patients: camma 2 study results | joshua richter, md | eha 2024
-
1:59
how do immunotherapies play a role in frail patients?
-
7:34
what is the future of cellular and immune therapies in myeloma?
-
0:39
healthtree 2.0 launch trailer
-
54:11
nursing care and frailty in myeloma
-
8:50
how is frailty score determined? it this standardized? what is a revised myeloma comorbidity score?
-
0:45
unmet needs that remain for patients with al amyloidosis who fail frontline treatment
-
1:43
ide-cel therapy for multiple myeloma with renal impairment
-
3:46
fitness: investigating frailty-adjusted therapy in transplant non-eligible patients with ndmm
-
2:18
t cell re-direction therapy | joshua richter, md | eha 2022